Back
Coherus Oncology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
CHRS
Coherus Oncology, Inc.
Last Price:
$1.35
Seasonality Move:
0.05%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CHRS is experiencing slight selling pressure.
Coherus Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.37 | Sell |
| 20-day SMA: | 1.32 | Buy |
| 50-day SMA: | 1.42 | Sell |
| 200-day SMA: | 1.13 | Buy |
| 8-day EMA: | 1.36 | Sell |
| 20-day EMA: | 1.34 | Buy |
| 50-day EMA: | 1.35 | Sell |
| 200-day EMA: | 0.89 | Buy |
Coherus Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 49.76 | Sell |
| Chaikin Money Flow: | -63632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.2 - 1.38) | Buy |
| Bollinger Bands (100): | (1.12 - 1.62) | Sell |
Coherus Oncology, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Coherus Oncology, Inc. Stock
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.34 while CHRS 8-day simple moving average is 1.37, which is a Sell signal.
-
The stock price of CHRS is 1.34 while Coherus Oncology, Inc. 20-day SMA is 1.32, which makes it a Buy.
-
Coherus Oncology, Inc. 50-day simple moving average is 1.42 while CHRS share price is 1.34, making it a Sell technically.
-
CHRS stock price is 1.34 and Coherus Oncology, Inc. 200-day simple moving average is 1.13, creating a Buy signal.
CHRS Technical Analysis vs Fundamental Analysis
Sell
48
Coherus Oncology, Inc. (CHRS)
is a Sell
Is Coherus Oncology, Inc. a Buy or a Sell?
-
Coherus Oncology, Inc. stock is rated a SellThe current Coherus Oncology, Inc. [CHRS] share price is $1.34. The Score for CHRS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Coherus Oncology, Inc. Stock Info
Market Cap:
162M
Price in USD:
1.34
Share Volume:
318.2K
Coherus Oncology, Inc. 52-Week Range
52-Week High:
1.89
52-Week Low:
0.71
Sell
48
Coherus Oncology, Inc. (CHRS)
is a Sell
Coherus Oncology, Inc. Share Price Forecast
-
What is the Coherus Oncology, Inc. stock price today?The Coherus Oncology, Inc. stock price is 1.34 USD today.
-
Will CHRS stock go up or go down?Coherus Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Coherus Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Coherus Oncology, Inc. is overvalued.
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.34 while CHRS 8-day exponential moving average is 1.36, which is a Sell signal.
-
The stock price of CHRS is 1.34 while Coherus Oncology, Inc. 20-day EMA is 1.34, which makes it a Buy.
-
Coherus Oncology, Inc. 50-day exponential moving average is 1.35 while CHRS share price is 1.34, making it a Sell technically.
-
CHRS stock price is 1.34 and Coherus Oncology, Inc. 200-day simple moving average is 0.89, creating a Buy signal.
Fundamental Analysis of Coherus Oncology, Inc.
Is Coherus Oncology, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and an increase next year of $0.84 per share.
Technical Analysis of Coherus Oncology, Inc.
Should I short Coherus Oncology, Inc. stock?
-
CHRS Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Coherus Oncology, Inc. is a Buy
-
Coherus Oncology, Inc. Relative Strength Index (RSI) is 49.76, which suggest Coherus Oncology, Inc. is oversold
-
The Bollinger Bands (25) for Coherus Oncology, Inc. is (1.2 - 1.38), which suggest Coherus Oncology, Inc. is a Sell
-
The Bollinger Bands (100) for Coherus Oncology, Inc. is (1.12 - 1.62), which suggest Coherus Oncology, Inc. is a Sell
* Coherus Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.